1

Why pharmaceutical firms may prefer to invest in drugs over vaccines

HANOVER, N.H. – March 2, 2016 – When it comes to addressing disease, many industry observers and public health advocates believe that pharmaceutical companies prefer to invest in drugs rather than vaccines, as preventives are perceived to be inherently less profitable. A Harvard-Dartmouth study on preventives versus treatments published in theQuarterly Journal of EconomicsĀ and recently summarized inĀ “VOX EU”, offers a …